Skip to main content

Table 3 Efficacy results

From: Efficacy and safety of Vinflunine for advanced or metastatic urothelial carcinoma in routine practice based on the French multi-centre CURVE study

ITT population

N = 134

Best Overall Response

 

Complete Response (n, %)

7 (5.2 %)

Partial Response (n, %)

23 (17.2 %)

Stable Disease (n, %)

38 (28.4 %)

Response Rate (CR + PR) (%, range)

30 (22.4 %)

Disease Control (CR + PR + SD) (%, range)

68 (50.7 %)

Median duration of response (month, range)

4.9 [3.2–6.5]

Median duration of stabilization (month, range)

7.8 [5.7–9.4]